iab-business and finance

Mental health is causing a growing proportion of students to consider dropping out, a study suggests

CNN — Isabelle, a 20-year-old student, is no stranger to hard work. She graduated high school a year early and spent most of 2021 holding down three jobs. But when she started college this fall, she felt like she was “sinking.” She knew that she hadn’t felt like herself during the first semester: her bubbly …

Mental health is causing a growing proportion of students to consider dropping out, a study suggests Read More »

It’s unclear if NY hush money grand jury will convene Thursday as Trump’s legal drama reaches a climax

CNN — The extraordinary legal jeopardy surrounding Donald Trump is peaking at the same time as the former president advances in the 2024 Republican primaries, which are increasingly dominated by criminal investigations in New York, Washington and Atlanta. But there is no public word on when or if an indictment might be filed, leaving the …

It’s unclear if NY hush money grand jury will convene Thursday as Trump’s legal drama reaches a climax Read More »

Vulnerable Americans remained undecided about another round of Covid-19 boosters this spring

CNN — US officials are considering whether to offer people at high risk of severe Covid-19 the chance to receive another bivalent booster, according to a source familiar with the discussions, who spoke on condition of anonymity because they were not authorized to share details of current discussions. While most Americans happily put pandemic precautions …

Vulnerable Americans remained undecided about another round of Covid-19 boosters this spring Read More »

Insurance pre-authorization requirements can lead to “devastating” delays

When Paula Chestnut needed hip replacement surgery last year, a pre-op X-ray revealed abnormalities in her chest. As a smoker for 40 years, Kesten was at high risk of lung cancer. A specialist in Los Angeles recommended that the 67-year-old undergo an MRI, a high-resolution image that can help detect the disease. But her MRI …

Insurance pre-authorization requirements can lead to “devastating” delays Read More »

Ozempic shortage: Diabetes patients at risk as TikTok and telehealth prescriptions drive drug demand

CNN — Telehealth and social media are playing an important role in driving demand for Ozempic, a prescription drug that treats type 2 diabetes, experts told CNN. The current shortage of drugs has limited access for diabetes patients who rely on them to control their blood sugar. Digital health companies are making drugs like Ozempic …

Ozempic shortage: Diabetes patients at risk as TikTok and telehealth prescriptions drive drug demand Read More »

Sanofi becomes latest drugmaker to announce insulin price cuts, capping costs at $35 for privately insured

CNN — Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the U.S., by 78% and setting a monthly cap of $35 for those with private insurance, the company said Thursday. The change takes effect on January 1. The move follows similar ones by Eli Lilly and Novo Nordisk this …

Sanofi becomes latest drugmaker to announce insulin price cuts, capping costs at $35 for privately insured Read More »

Maternal mortality in the US has risen for another year, according to CDC data

CNN — As women continue to die due to pregnancy or childbirth each year in the United States, new federal data shows the nation’s maternal mortality rate rose sharply again in 2021, with rates among black women more than double than those of white women. Experts said the ongoing maternal mortality crisis in the United …

Maternal mortality in the US has risen for another year, according to CDC data Read More »

Sanofi becomes latest drugmaker to announce insulin price cuts, capping costs at $35 for privately insured

CNN — Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the U.S., by 78% and setting a monthly cap of $35 for those with private insurance, the company said Thursday. The change takes effect on January 1. The move follows similar ones by Eli Lilly and Novo Nordisk this …

Sanofi becomes latest drugmaker to announce insulin price cuts, capping costs at $35 for privately insured Read More »